Literature DB >> 29224509

Algorithms used to identify ventricular arrhythmias and sudden cardiac death in retrospective studies: a systematic literature review.

Yizhou Ye1, E Paul Larrat1, Aisling R Caffrey2.   

Abstract

Drug-induced QT interval prolongation may increase the risk of sudden cardiac death or ventricular arrhythmias (SCD/VA), and therefore affects the safety profile of medications. Administrative databases can be used to inform pharmacoepidemiologic drug safety studies for such rare events. In order to compare event rates between studies, validated operational definitions of these events are needed. We conducted a systematic literature review in PubMed to identify algorithms for SCD/VA. Twenty-two studies were included in the review. Fifteen (68%) studies evaluated International Classification of Diseases, 9th revision (ICD-9) based medical data, of which six utilized a common, validated operational definition. This algorithm was based on principal hospitalization discharge diagnosis or first-listed emergency department visit diagnosis, with an average positive predictive value (PPV) of 85%. Four studies evaluated ICD-9 based death data, of which three utilized a common algorithm with an average PPV of 88%. Further validation of ICD, 10th revision algorithms are needed. In conclusion, we identified a validated algorithm for SCD/VA in medical data, as well as in death data. As such, to ensure comparability between new research and the existing literature, pharmacoepidemiologic research in this area should utilize common, validated algorithms, such as the ones identified in our review, to operationally define these events.

Entities:  

Keywords:  databases; literature review; retrospective study; sudden cardiac death; ventricular arrhythmias

Mesh:

Year:  2017        PMID: 29224509      PMCID: PMC5933590          DOI: 10.1177/1753944717745493

Source DB:  PubMed          Journal:  Ther Adv Cardiovasc Dis        ISSN: 1753-9447


  32 in total

Review 1.  Drug induced QT prolongation and torsades de pointes.

Authors:  Yee Guan Yap; A John Camm
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

Review 2.  Implantable defibrillators and sudden cardiac death.

Authors:  Mark Josephson; Hein J J Wellens
Journal:  Circulation       Date:  2004-06-08       Impact factor: 29.690

3.  Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study.

Authors:  Catherine B Johannes; Cristina Varas-Lorenzo; Lisa J McQuay; Kirk D Midkiff; Daniel Fife
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-09       Impact factor: 2.890

4.  Serious ventricular arrhythmias among users of cisapride and other QT-prolonging agents in the United States.

Authors:  Cheryl Enger; Clorinda Cali; Alexander M Walker
Journal:  Pharmacoepidemiol Drug Saf       Date:  2002-09       Impact factor: 2.890

5.  Antidepressants and the risk of sudden cardiac death and ventricular arrhythmia.

Authors:  Charles E Leonard; Warren B Bilker; Craig Newcomb; Stephen E Kimmel; Sean Hennessy
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-07-28       Impact factor: 2.890

6.  Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythmia: a nationwide case-crossover study.

Authors:  Hung-Lin Chen; Fei-Yuan Hsiao
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-06-22       Impact factor: 2.890

7.  Cisapride and ventricular arrhythmia.

Authors:  Sean Hennessy; Charles E Leonard; Craig Newcomb; Stephen E Kimmel; Warren B Bilker
Journal:  Br J Clin Pharmacol       Date:  2008-07-23       Impact factor: 4.335

8.  Trends in hospital treatment of ventricular arrhythmias among Medicare beneficiaries, 1985 to 1995.

Authors:  Kathryn M McDonald; Mark A Hlatky; Olga Saynina; Jeffrey Geppert; Alan M Garber; Mark B McClellan
Journal:  Am Heart J       Date:  2002-09       Impact factor: 4.749

9.  Validation of diagnostic codes for outpatient-originating sudden cardiac death and ventricular arrhythmia in Medicaid and Medicare claims data.

Authors:  Sean Hennessy; Charles E Leonard; Cristin P Freeman; Rajat Deo; Craig Newcomb; Stephen E Kimmel; Brian L Strom; Warren B Bilker
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-06       Impact factor: 2.890

10.  Antipsychotic drugs and the risk of ventricular arrhythmia and/or sudden cardiac death: a nation-wide case-crossover study.

Authors:  Chi-Shin Wu; Yu-Ting Tsai; Hui-Ju Tsai
Journal:  J Am Heart Assoc       Date:  2015-02-23       Impact factor: 5.501

View more
  3 in total

1.  Diagnostic Algorithms for Cardiovascular Death in Administrative Claims Databases: A Systematic Review.

Authors:  Sonal Singh; Hassan Fouayzi; Kathryn Anzuoni; Leah Goldman; Jea Young Min; Marie Griffin; Carlos G Grijalva; James A Morrow; Christine C Whitmore; Charles E Leonard; Mano Selvan; Vinit Nair; Yunping Zhou; Sengwee Toh; Andrew Petrone; James Williams; Elnara Fazio-Eynullayeva; Richard Swain; D Tyler Coyle; Susan Andrade
Journal:  Drug Saf       Date:  2019-04       Impact factor: 5.606

2.  Disparities in Care and Mortality Among Homeless Adults Hospitalized for Cardiovascular Conditions.

Authors:  Rishi K Wadhera; Sameed Ahmed M Khatana; Eunhee Choi; Ginger Jiang; Changyu Shen; Robert W Yeh; Karen E Joynt Maddox
Journal:  JAMA Intern Med       Date:  2020-03-01       Impact factor: 21.873

3.  Cardiovascular Safety of Metoclopramide Compared to Domperidone: A Population-Based Cohort Study.

Authors:  Andrea Cowan; Amit X Garg; Eric McArthur; Flory Muanda Tsobo; Matthew A Weir
Journal:  J Can Assoc Gastroenterol       Date:  2020-12-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.